Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.
Soriano
Vincent
V
Department of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain. vsoriano@dragonet.es
Puoti
Massimo
M
Bonacini
Maurizio
M
Brook
Gary
G
Cargnel
Antonietta
A
Rockstroh
Juergen
J
Thio
Chloe
C
Benhamou
Yves
Y
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D015897:Comorbidity; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018450:Disease Progression; D016903:Drug Monitoring / Q000379:methods; D000068679:Emtricitabine; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D000068698:Tenofovir
D000998:Antiviral Agents; D016898:Interferon-alpha; D063065:Organophosphonates; D003841:Deoxycytidine; D019259:Lamivudine; C053001:adefovir; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine